Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-4-16
pubmed:databankReference
pubmed:abstractText
In 1996, Serratia marcescens KU3838 was isolated from the urine of a patient with a urinary tract infection at a hospital in northern Japan and was found to contain the plasmid pKU501. Previously, we determined that pKU501 carries bla(IMP) and the genes for TEM-1-type beta-lactamases as well as producing both types of beta-lactamases (H. Yano, A. Kuga, K. Irinoda, R. Okamoto, T. Kobayashi, and M. Inoue, J. Antibiot. 52:1135-1139, 1999). pKU502 is a recombinant plasmid that contains a 1.5-kb DNA fragment, including the metallo-beta-lactamase gene, and is obtained by PCR amplification of pKU501. The sequence of the metallo-beta-lactamase gene in pKU502 was determined and revealed that this metallo-beta-lactamase gene differed from the gene encoding IMP-1 by one point mutation, leading to one amino acid substitution: 640-A in the base sequence of the IMP-1 gene was replaced by G, and Ser-196 was replaced by Gly in the mature enzyme. This enzyme was designated IMP-6. The strains that produced IMP-6 were resistant to carbapenems. The MICs of panipenem and especially meropenem were higher than the MIC of imipenem for these strains. The k(cat)/K(m) value of IMP-6 was about sevenfold higher against meropenem than against imipenem, although the MIC of meropenem for KU1917, which produced IMP-1, was lower than that of imipenem, and the MIC of panipenem was equal to that of imipenem. These results support the hypothesis that IMP-6 has extended substrate profiles against carbapenems. However, the activity of IMP-6 was very low against penicillin G and piperacillin. These results suggest that IMP-6 acquired high activity against carbapenems, especially meropenem, via the point mutation but in the process lost activity against penicillins. Although IMP-6 has reduced activity against penicillins due to this point mutation, pKU501 confers resistance to a variety of antimicrobial agents because it also produces TEM-1-type enzyme.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-10093989, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-10097676, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-10103196, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-10103197, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-10489986, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-10565933, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-10695677, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-10770756, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-10898670, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-1399950, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-1509257, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-1901695, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-2020554, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-271968, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-2808204, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-2970625, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-3279015, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-3327753, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-3530125, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-6109327, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-6279559, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-6300947, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-7574506, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-7726496, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-7783675, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-7785978, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-7926668, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-8141584, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-8557603, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-8619581, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-8834878, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-8889716, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-8913462, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-9021171, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-9023666, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-9182100, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-9687398, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-9710671, http://linkedlifedata.com/resource/pubmed/commentcorrection/11302793-9712464
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1343-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2001
pubmed:articleTitle
Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.
pubmed:affiliation
Department of Microbiology, School of Medicine and Environmental Infectious Disease, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa 228-8555, Japan. d300042c@stcc.nagasaki-u.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't